Sadhana Nitrochem (SADHNANIQ)₹2.32−2.11%Commodity Chemicals
In the Sep 2026 quarter (consolidated), Sadhana Nitrochem reported sales of ₹42.83 Cr, up 1,480.4% from Sep 2025, and net profit of ₹1.38 Cr. For the year to Mar 2026, sales were ₹50.09 Cr and net profit −₹86.31 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44.14 | 64.69 | 36.15 | 42.92 | 37.12 | 49.54 | 28.15 | 2.71 | 9.78 | 9.13 | 27.27 | 42.83 |
| Expenses | 32.74 | 55.35 | 26.53 | 34.65 | 25.90 | 36.30 | 26.22 | 19.70 | 25.01 | 32.00 | 24.93 | 35.17 |
| Operating Profit | 11.43 | 9.31 | 9.65 | 8.30 | 11.25 | 13.25 | 1.95 | −17.00 | −15.22 | −22.87 | 2.33 | 7.68 |
| OPM % | 25.8% | 14.3% | 26.6% | 19.3% | 30.2% | 26.7% | 6.9% | −629.0% | −155.7% | −250.6% | 8.5% | 17.9% |
| Other Income | 0.76 | 2.46 | 0.28 | 1.16 | 0.48 | −0.11 | 4.47 | −0.46 | 1.19 | 3.33 | 3.70 | 0.25 |
| Interest | 4.35 | 4.11 | 4.14 | 4.41 | 4.63 | 4.28 | 4.00 | 4.84 | 6.86 | 10.70 | 3.18 | 3.13 |
| Depreciation | 3.84 | 3.48 | 3.99 | 4.00 | 3.35 | 3.84 | 4.64 | 3.67 | 3.86 | 4.12 | 2.94 | 3.25 |
| Profit before tax | 3.99 | 4.18 | 1.79 | 1.05 | 3.73 | 4.98 | −2.25 | −26.07 | −24.83 | −34.45 | −0.10 | 1.55 |
| Tax % | 76.7% | 87.6% | 65.2% | 75.1% | 30.7% | 17.6% | −5.4% | −1.7% | 1.7% | −2.1% | 511.1% | 11.1% |
| Net Profit | 0.94 | 0.53 | 0.63 | 0.27 | 2.59 | 4.11 | −2.13 | −25.66 | −25.23 | −33.74 | −0.56 | 1.38 |
| EPS (Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | −0.02 | −0.10 | −0.09 | −0.12 | 0.00 | 0.00 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 36.07 | 55.07 | 114 | 267 | 106 | 103 | 132 | 143 | 190 | 166 | 50.09 | 89.01 |
| Expenses | 34.07 | 47.07 | 79.15 | 147 | 77.18 | 80.12 | 117 | 122 | 149 | 123 | 103 | 117 |
| Operating Profit | 2.01 | 8.02 | 35.10 | 120 | 29.08 | 23.04 | 15.04 | 21.04 | 41.08 | 42.07 | −53.12 | −28.08 |
| OPM % | 5.0% | 14.9% | 31.0% | 45.0% | 26.9% | 22.9% | 10.9% | 14.9% | 22.0% | 26.0% | −107.1% | −31.6% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.99 | 1.99 | 4.99 | 4.99 | 1.99 | 3.99 | 1.99 | 8.97 | 8.47 |
| Interest | 4.99 | 5.99 | 4.99 | 11.99 | 2.99 | 2.99 | 4.99 | 9.99 | 16.98 | 17.99 | 25.95 | 23.87 |
| Depreciation | 1.99 | 1.99 | 1.99 | 3.01 | 5.99 | 5.99 | 5.99 | 7.99 | 15.01 | 14.99 | 15.99 | 14.17 |
| Profit before tax | −5.02 | 1.01 | 28.09 | 107 | 22.08 | 19.06 | 9.03 | 6.02 | 13.03 | 12.03 | −87.30 | −57.83 |
| Tax % | 0.0% | 0.0% | −11.0% | 29.1% | 34.0% | 15.1% | 30.1% | 44.1% | 68.0% | 34.1% | −1.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −5.02 | 1.01 | 31.11 | 76.29 | 15.07 | 16.06 | 6.02 | 3.01 | 4.02 | 8.02 | −86.31 | −58.15 |
| EPS (Rs) | −0.03 | 0.00 | 0.12 | 0.27 | 0.06 | 0.07 | 0.03 | 0.02 | 0.02 | 0.04 | −0.30 | −0.21 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 47.0% | 95.0% | 91.1% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.02 | 9.01 | 9.01 | 9.01 | 9.03 | 9.02 | 14.04 | 20.04 | 20.06 | 25.08 | 33.10 | 297 |
| Reserves | −6.98 | −11.97 | 0.99 | 36.92 | 96.04 | 107 | 116 | 141 | 206 | 202 | 248 | 158 |
| Borrowings | 37.09 | 44.13 | 36.10 | 16.05 | 8.03 | 46.17 | 83.26 | 116 | 139 | 234 | 248 | 113 |
| Other Liabilities | 26.05 | 26.96 | 37.10 | 78.31 | 64.30 | 53.26 | 91.43 | 111 | 61.30 | 73.35 | 110 | 90.44 |
| Total Liabilities | 66.18 | 68.13 | 83.20 | 139 | 177 | 216 | 305 | 387 | 427 | 533 | 638 | 659 |
| Fixed Assets | 31.12 | 29.09 | 37.17 | 50.21 | 76.28 | 84.28 | 78.30 | 75.34 | 145 | 157 | 160 | 164 |
| CWIP | 9.01 | 9.01 | 8.99 | 11.01 | 1.99 | 14.99 | 23.01 | 67.97 | 27.99 | 53.04 | 100 | 78.03 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 5.01 | 6.01 | 6.01 | 7.01 | 6.02 | 6.01 | 0.00 | 0.00 |
| Other Assets | 26.05 | 30.03 | 37.04 | 78.07 | 94.12 | 111 | 197 | 236 | 248 | 318 | 379 | 416 |
| Inventories | 9.01 | 9.01 | 16.01 | 22.01 | 40.98 | 52.04 | 65.98 | 101 | 116 | 115 | 135 | 98.10 |
| Trade receivables | 6.98 | 12.97 | 9.99 | 14.98 | 15.97 | 28.93 | 48.91 | 40.96 | 65.88 | 126 | 122 | 133 |
| Cash & equivalents | 0.00 | 1.01 | 1.01 | 8.02 | 9.03 | 1.01 | 11.03 | 8.02 | 9.02 | 8.02 | 9.02 | 18.06 |
| Total Assets | 66.18 | 68.13 | 83.20 | 139 | 177 | 216 | 305 | 387 | 427 | 533 | 638 | 659 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 9.03 | −1.01 | 9.02 | 35.11 | 53.16 | −17.04 | 1.01 | −5.01 | −38.07 | −3.01 | 48.11 | −29.07 |
| Cash from investing activity | 0.00 | 0.00 | −1.01 | −6.01 | −25.02 | −22.03 | −23.01 | −39.01 | −53.02 | −65.03 | −89.09 | −46.03 |
| Cash from financing activity | −9.01 | 2.01 | −25.03 | −13.03 | −23.02 | 30.03 | 30.05 | 46.11 | 72.08 | 42.04 | 25.03 | 93.21 |
| Net cash flow | 0.00 | 1.01 | −16.04 | 16.06 | 5.01 | −9.03 | 7.03 | 2.01 | −19.07 | −26.08 | −16.06 | 18.06 |
| Capex | 0.00 | 0.00 | 1.01 | 6.02 | 21.07 | 22.06 | 9.04 | 41.14 | 48.15 | 66.23 | 94.38 | 64.22 |
| Free cash flow | 8.99 | −1.01 | 8.01 | 28.99 | 31.99 | −38.99 | −6.99 | −45.98 | −86.10 | −68.06 | −46.02 | −92.98 |
| CFO / OP % | −246.0% | −47.1% | 109.9% | 107.0% | 50.9% | 4.0% | 5.0% | 22.9% | −154.1% | −4.0% | 120.9% | 49.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 56 | 131 | 68 | 49 | 21 | 100 | 173 | 113 | 167 | 242 | 270 | 976 |
| Inventory days | 102 | 176 | 222 | 184 | 217 | 600 | 600 | — | — | — | — | 951 |
| Days payable | 227 | 396 | 351 | 196 | 65 | 255 | 235 | — | — | — | — | 466 |
| Cash conversion cycle | −68 | −88 | −59 | 37 | 174 | 446 | 539 | 113 | 167 | 242 | 270 | 1,462 |
| Working capital days | −212 | −322 | −128 | −108 | 23 | 68 | 94 | 70 | 206 | 178 | 149 | 733 |
| ROCE % | −12.9% | 0.0% | 16.0% | 62.1% | 136.0% | 18.1% | 12.0% | 6.0% | 5.0% | 7.0% | 6.0% | −11.0% |
For the Sep 2026 quarter, Sadhana Nitrochem reported sales of ₹42.83 Cr, up 1,480.4% year on year and net profit of ₹1.38 Cr. The operating margin was 17.9%.
Sadhana Nitrochem's sales for the year to Mar 2026 were ₹50.09 Cr; over the last twelve months they were ₹89.01 Cr.
Net profit for the year to Mar 2026 was −₹86.31 Cr, and −₹58.15 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.21.
Sadhana Nitrochem reported borrowings of ₹113 Cr at Mar 2026, against cash and equivalents of ₹18.06 Cr.
Cash from operations was −₹29.07 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹92.98 Cr.